Radiation Therapy Combined with Cisplatin Based Chemotherapy for the Patients with Locally Advanced Nasopharyngeal Cancer |
Son, Seok-Hyun
(Department of Radiation Oncology, Catholic University of Korea)
Kim, Ji-Yoon (Department of Radiation Oncology, Catholic University of Korea) Kim, Sung-Whan (Department of Radiation Oncology, Catholic University of Korea) Mun, Seong-Kwon (Department of Radiation Oncology, Catholic University of Korea) Cho, Seung-Ho (Department of Otolaryngology, Catholic University of Korea) Park, Young-Hak (Department of Otolaryngology, Catholic University of Korea) Hong, Young-Seon (Department of Hemato-Oncology, Catholic University of Korea) Kim, Yeon-Sil (Department of Radiation Oncology, Catholic University of Korea) |
1 | Hareyama M, Sakata K, Shirato H, et al: A prospective, randomized trial comparing neoadjuvant chemotherapy with radiotherapy alone in patients with advanced nasopharyngeal carcinoma. Cancer. 2002;94:2217-2223 DOI ScienceOn |
2 | Yun SM, Kim JC, Park IK: Combined modality treatment in nasopharyngeal carcinoma. J Korean Soc Ther Radiol Oncol. 2001;19 (2 ):100-106 과학기술학회마을 |
3 | Rossi A, Molinari R, Boracchi P, et al: Adjuvant chemotherapy with vincristine, cyclophosphamide, and doxorubicin after radiotherapy in locoregional nasopharyngeal cancer: results of a 4-year multicenter randomized study. J Clin Oncol. 1988;6:1401-1410 DOI |
4 | Chan AC, Teo PL, Ngan RK, et al: Concurrent chemotherapyradiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: progression-free survival analysis of a phase III randomized trial. J Clin Oncol. 2002;20:2038-2044 DOI ScienceOn |
5 | Ma J, Mai HQ, Hong MH, et al: Results of a prospective randomized trial comparing neoadjuvant chemotherapy plus radiotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma. J Clin Oncol. 2001;19:1350-1357 DOI |
6 | Sanguinetti G, Geara FB, Garden AS, et al: Carcinoma of the nasopharynx treated by radiotherapy alone: determinants of local and regional control. Int J Radiat Oncol Biol Phys. 1997;37:985-996 DOI ScienceOn |
7 | DeVita VT, Hellman S, Rosenberg SA: Cancer: Principles & Practice of oncology. ed. Philadelphia; Lippincott Williams & Wilkins, 2005:712-713 |
8 | Chi KH, Chang YC, Guo WY, et al: A Phase III study of adjuvant chemotherapy in advanced nasopharyngeal carcinoma patients. Int J Radiat Oncol Biol Phys. 2002;52:1238-1244 DOI ScienceOn |
9 | Qin D, Hu Y, Yan J, et al: Analysis of 1379 patients with nasopharyngeal carcinoma treated by radiation. Cancer. 1988;61:1117-1124 DOI ScienceOn |
10 | Lin JC, Jan JS, Hsu CY, et al: Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: positive effect on overall and progressionfree survival. J Clin Oncol. 2003;21:631-637 DOI ScienceOn |
11 | Chua DT, Sham JT, Choy D, et al: Preliminary report of the Asian-Oceanian Clinical Oncology Association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal carcinoma. Cancer. 1998;83:2270-2283 DOI ScienceOn |
12 | Cvitkovic E and the International Nasopharynx Cancer Study Group: Preliminary results of a randomized trial comparing neoadjuvant chemotherapy (cisplatin, epirubicin, bleomycin ) plus radiotherapy vs. radiotherapy alone in stage IV $(>=N_2,\;M_0)$ undifferentiated nasopharyngeal carcinoma: a positive effect on progression-free survival. Int J Radiat Oncol Biol Phys. 1996;35:463-469 DOI ScienceOn |
13 | Al-Sarraf M, LeBlanc M, Giri PG, et al: Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized intergroup study 0099. J Clin Oncol. 1998;16:1310-1317 DOI |